Evidence map›Paper›PMID 28330236›Full record

Article3 Biotech2016

Xylanase production from Penicillium citrinum isolate HZN13 using response surface methodology and characterization of immobilized xylanase on glutaraldehyde-activated calcium-alginate beads.

Zabin K Bagewadi, Sikandar I Mulla, Yogesh Shouche, Harichandra Z Ninnekar

Open access · hybridAbstract read
In one paragraph

Article in 3 Biotech, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Response surface methodology based optimization of keratinase fromSaudi journal of biological sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Use of Wheat Straw for Value-Added Product Xylanase byJournal of fungi (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zabin K BagewadiDepartment of Biochemistry, Karnatak University, Dharwad, 580 003, Karnataka, India.
Sikandar I MullaDepartment of Biochemistry, Karnatak University, Dharwad, 580 003, Karnataka, India.
Yogesh ShoucheNational Centre for Cell Science, Pune University Campus, Ganeshkhind, Pune, 411 007, Maharashtra, India.
Harichandra Z NinnekarDepartment of Biochemistry, Karnatak University, Dharwad, 580 003, Karnataka, India. hzninnekar@yahoo.com.ORCID http://orcid.org/0000-0002-3435-6457
Karnatak University · INNational Centre for Cell Science · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study reports the production of high-level cellulase-free xylanase from Penicillium citrinum isolate HZN13. The variability in xylanase titers was assessed under both solid-state (SSF) and submerged (SmF) fermentation. SSF was initially optimized with different agro-waste residues, among them sweet sorghum bagasse was found to be the best substrate that favored maximum xylanase production (9643 U/g). Plackett-Burman and response surface methodology employing central composite design were used to optimize the process parameters for the production of xylanase under SSF. A second-order quadratic model and response surface method revealed the optimum conditions for xylanase production (sweet sorghum bagasse 25 g/50 ml; ammonium sulphate 0.36 %; yeast extract 0.6 %; pH 4; temperature 40 °C) yielding 30,144 U/g. Analysis of variance (ANOVA) showed a high correlation coefficient (R

Indexed as

Enzymatic hydrolysisImmobilizationPenicillium citrinumResponse surface methodologySweet sorghum bagasseXylanase

Identifiers

PMID28330236
PMCPMC4980835
OpenAlexW2499290471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.